Goldman Sachs Says Crowd Misreads This Medical Robotics Giant
The crowd may be selling Intuitive Surgical too quickly. A Goldman Sachs perspective argues the long-term setup remai...
Mortgage Rate Comparison Tool 2024 enables rapid side-by-side rate comparisons, helping you discover optimal mortgage terms efficiently.
17,382 articlesThe crowd may be selling Intuitive Surgical too quickly. A Goldman Sachs perspective argues the long-term setup remai...
Matrixport’s fear index shows mounting pessimism as Bitcoin whipsaws in a volatile market. While downside risk remain...
IBM shares plunged after a softer than expected Q2 outlook, triggering a sharp one day drop. Analysts remain split, w...
Rivian is targeting a major production shift with the R2 lineup. This guide weighs the bull and bear cases for rivian...
Asia’s top travel platform Klook aims for Western growth amid a fintech-friendly US landscape. Analysts say U.S. part...
Goodyear reports a strong Q4 with $105 million in profit, while an investor increases exposure to $15 million. This p...
New SECURE 2.0 rules force high earners lose $1,900 in pretax 401(k) benefits. HSAs are gaining traction as a tax-eff...
Alphabet reportedly priced a rare 100-year bond to back AI and data-center expansion, a move that stirs debate on lon...
Intel stock looks beaten in the near term, but long-term possibilities remain. This guide breaks down the factors tha...
Microsoft stock pulled back early in 2026, turning headlines into a real question for investors: down 15%, should mic...
SpaceX aims to put AI compute in orbit by 2028, a move that could reshape data centers. This article breaks down the ...
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...